Sign in
4

Changes in Ownership

Petros Pharmaceuticals, Inc. Filed Acc 0001567619-21-005214

Options or other derivatives

  • Pres. & Chief Comm. Officer acquired 215,669 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Boctor Fady · Pres. & Chief Comm. Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-19 Grant or award : show line 1 in the form Stock Options (right to buy) +215,669 215,669 D
Loading xslF345X03/doc1.xml…